131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients - Garaventa, A; Bellagamba, O; Lo Piccolo, M S (Br J Cancer, 1999)
et al.